Global (United States, European Union and China) Abacavir

Abacavir Comprehensive Study by Type (Tablet, Oral Solution), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Players and Region - Global Market Outlook to 2026

Abacavir Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Abacavir Market Overview:
Abacavir (ABC) is a medication used to avoid and treat HIV/AIDS. This drug is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This is help to less chance of getting HIV complications (including new infections, cancer) and increases your quality of life. Abacavir goes to a class of drugs known as nucleoside reverse transcriptase inhibitors-NRTI.

Growth Drivers
  • Growing Worldwide Occurrence of HIV/Aids
  • Increasing Number of Blood Transfusions and Blood Donations Globally

Roadblocks
  • High Cost of HIV Medicines

Opportunities
  • Growth Opportunities for HIV Diagnosis in Emerging Economies
  • Rising Research and Development for Early Diagnosis, Treatment, and Prevention Form HIV-AIDS


Competitive Landscape:
The Abacavir market is characterized by the presence of established global players. The market is competitive and the vendors are increasingly competing against each other based on factors such as aggressive pricing, product differentiation, capital support for a product, and distribution partnerships, and research advancements.
Some of the key players profiled in the report are GSK (United Kingdom), Aurobindo (India), Hycultec (Germany), Lupin Limited (India), Sigma-Aldrich (United States), ViiV Healthcare (United Kingdom), Cayman Chemical (United States), Mylan (United States) and TCI Chemicals (India). Analyst at AMA Research see United States Players to retain maximum share of Global Abacavir market by 2026. Considering Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacy will boost the Abacavir market.

December 17, 1998, FDA granted accelerated approval for Ziagen (abacavir), Glaxo Wellcome, to treat HIV-1 in adults and children.

What Can be Explored with the Abacavir Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Abacavir Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Abacavir
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Abacavir market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Abacavir market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Government Regulatory Bodies, Private Research Organizations, Government Research Organizations, Industry Associations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Tablet
  • Oral Solution
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Worldwide Occurrence of HIV/Aids
      • 3.2.2. Increasing Number of Blood Transfusions and Blood Donations Globally
    • 3.3. Market Trends
      • 3.3.1. Increasing Government Initiatives for HIV-ADIS Free Population
      • 3.3.2. Rising Research and Development Regarding Abacavir
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Abacavir, by Type, Distribution Channel and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Abacavir (Value)
      • 5.2.1. Global Abacavir by: Type (Value)
        • 5.2.1.1. Tablet
        • 5.2.1.2. Oral Solution
      • 5.2.2. Global Abacavir by: Distribution Channel (Value)
        • 5.2.2.1. Hospital Pharmacy
        • 5.2.2.2. Retail Pharmacy
        • 5.2.2.3. Online Pharmacy
      • 5.2.3. Global Abacavir Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Abacavir (Volume)
      • 5.3.1. Global Abacavir by: Type (Volume)
        • 5.3.1.1. Tablet
        • 5.3.1.2. Oral Solution
      • 5.3.2. Global Abacavir by: Distribution Channel (Volume)
        • 5.3.2.1. Hospital Pharmacy
        • 5.3.2.2. Retail Pharmacy
        • 5.3.2.3. Online Pharmacy
      • 5.3.3. Global Abacavir Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Abacavir (Price)
      • 5.4.1. Global Abacavir by: Type (Price)
  • 6. Abacavir: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GSK (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Aurobindo (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hycultec (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Lupin Limited (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sigma-Aldrich (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ViiV Healthcare (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cayman Chemical (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Mylan (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. TCI Chemicals (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Abacavir Sale, by Type, Distribution Channel and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Abacavir (Value)
      • 7.2.1. Global Abacavir by: Type (Value)
        • 7.2.1.1. Tablet
        • 7.2.1.2. Oral Solution
      • 7.2.2. Global Abacavir by: Distribution Channel (Value)
        • 7.2.2.1. Hospital Pharmacy
        • 7.2.2.2. Retail Pharmacy
        • 7.2.2.3. Online Pharmacy
      • 7.2.3. Global Abacavir Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Abacavir (Volume)
      • 7.3.1. Global Abacavir by: Type (Volume)
        • 7.3.1.1. Tablet
        • 7.3.1.2. Oral Solution
      • 7.3.2. Global Abacavir by: Distribution Channel (Volume)
        • 7.3.2.1. Hospital Pharmacy
        • 7.3.2.2. Retail Pharmacy
        • 7.3.2.3. Online Pharmacy
      • 7.3.3. Global Abacavir Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Abacavir (Price)
      • 7.4.1. Global Abacavir by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Abacavir: by Type(USD Million)
  • Table 2. Abacavir Tablet , by Region USD Million (2015-2020)
  • Table 3. Abacavir Oral Solution , by Region USD Million (2015-2020)
  • Table 4. Abacavir: by Distribution Channel(USD Million)
  • Table 5. Abacavir Hospital Pharmacy , by Region USD Million (2015-2020)
  • Table 6. Abacavir Retail Pharmacy , by Region USD Million (2015-2020)
  • Table 7. Abacavir Online Pharmacy , by Region USD Million (2015-2020)
  • Table 8. South America Abacavir, by Country USD Million (2015-2020)
  • Table 9. South America Abacavir, by Type USD Million (2015-2020)
  • Table 10. South America Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 11. Brazil Abacavir, by Type USD Million (2015-2020)
  • Table 12. Brazil Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 13. Argentina Abacavir, by Type USD Million (2015-2020)
  • Table 14. Argentina Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 15. Rest of South America Abacavir, by Type USD Million (2015-2020)
  • Table 16. Rest of South America Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 17. Asia Pacific Abacavir, by Country USD Million (2015-2020)
  • Table 18. Asia Pacific Abacavir, by Type USD Million (2015-2020)
  • Table 19. Asia Pacific Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 20. China Abacavir, by Type USD Million (2015-2020)
  • Table 21. China Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 22. Japan Abacavir, by Type USD Million (2015-2020)
  • Table 23. Japan Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 24. India Abacavir, by Type USD Million (2015-2020)
  • Table 25. India Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 26. South Korea Abacavir, by Type USD Million (2015-2020)
  • Table 27. South Korea Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 28. Taiwan Abacavir, by Type USD Million (2015-2020)
  • Table 29. Taiwan Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 30. Australia Abacavir, by Type USD Million (2015-2020)
  • Table 31. Australia Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 32. Rest of Asia-Pacific Abacavir, by Type USD Million (2015-2020)
  • Table 33. Rest of Asia-Pacific Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 34. Europe Abacavir, by Country USD Million (2015-2020)
  • Table 35. Europe Abacavir, by Type USD Million (2015-2020)
  • Table 36. Europe Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 37. Germany Abacavir, by Type USD Million (2015-2020)
  • Table 38. Germany Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 39. France Abacavir, by Type USD Million (2015-2020)
  • Table 40. France Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 41. Italy Abacavir, by Type USD Million (2015-2020)
  • Table 42. Italy Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 43. United Kingdom Abacavir, by Type USD Million (2015-2020)
  • Table 44. United Kingdom Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 45. Netherlands Abacavir, by Type USD Million (2015-2020)
  • Table 46. Netherlands Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 47. Rest of Europe Abacavir, by Type USD Million (2015-2020)
  • Table 48. Rest of Europe Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 49. MEA Abacavir, by Country USD Million (2015-2020)
  • Table 50. MEA Abacavir, by Type USD Million (2015-2020)
  • Table 51. MEA Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 52. Middle East Abacavir, by Type USD Million (2015-2020)
  • Table 53. Middle East Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 54. Africa Abacavir, by Type USD Million (2015-2020)
  • Table 55. Africa Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 56. North America Abacavir, by Country USD Million (2015-2020)
  • Table 57. North America Abacavir, by Type USD Million (2015-2020)
  • Table 58. North America Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 59. United States Abacavir, by Type USD Million (2015-2020)
  • Table 60. United States Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 61. Canada Abacavir, by Type USD Million (2015-2020)
  • Table 62. Canada Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 63. Mexico Abacavir, by Type USD Million (2015-2020)
  • Table 64. Mexico Abacavir, by Distribution Channel USD Million (2015-2020)
  • Table 65. Abacavir Sales: by Type(K Units)
  • Table 66. Abacavir Sales Tablet , by Region K Units (2015-2020)
  • Table 67. Abacavir Sales Oral Solution , by Region K Units (2015-2020)
  • Table 68. Abacavir Sales: by Distribution Channel(K Units)
  • Table 69. Abacavir Sales Hospital Pharmacy , by Region K Units (2015-2020)
  • Table 70. Abacavir Sales Retail Pharmacy , by Region K Units (2015-2020)
  • Table 71. Abacavir Sales Online Pharmacy , by Region K Units (2015-2020)
  • Table 72. South America Abacavir Sales, by Country K Units (2015-2020)
  • Table 73. South America Abacavir Sales, by Type K Units (2015-2020)
  • Table 74. South America Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 75. Brazil Abacavir Sales, by Type K Units (2015-2020)
  • Table 76. Brazil Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 77. Argentina Abacavir Sales, by Type K Units (2015-2020)
  • Table 78. Argentina Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 79. Rest of South America Abacavir Sales, by Type K Units (2015-2020)
  • Table 80. Rest of South America Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 81. Asia Pacific Abacavir Sales, by Country K Units (2015-2020)
  • Table 82. Asia Pacific Abacavir Sales, by Type K Units (2015-2020)
  • Table 83. Asia Pacific Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 84. China Abacavir Sales, by Type K Units (2015-2020)
  • Table 85. China Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 86. Japan Abacavir Sales, by Type K Units (2015-2020)
  • Table 87. Japan Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 88. India Abacavir Sales, by Type K Units (2015-2020)
  • Table 89. India Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 90. South Korea Abacavir Sales, by Type K Units (2015-2020)
  • Table 91. South Korea Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 92. Taiwan Abacavir Sales, by Type K Units (2015-2020)
  • Table 93. Taiwan Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 94. Australia Abacavir Sales, by Type K Units (2015-2020)
  • Table 95. Australia Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 96. Rest of Asia-Pacific Abacavir Sales, by Type K Units (2015-2020)
  • Table 97. Rest of Asia-Pacific Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 98. Europe Abacavir Sales, by Country K Units (2015-2020)
  • Table 99. Europe Abacavir Sales, by Type K Units (2015-2020)
  • Table 100. Europe Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 101. Germany Abacavir Sales, by Type K Units (2015-2020)
  • Table 102. Germany Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 103. France Abacavir Sales, by Type K Units (2015-2020)
  • Table 104. France Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 105. Italy Abacavir Sales, by Type K Units (2015-2020)
  • Table 106. Italy Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 107. United Kingdom Abacavir Sales, by Type K Units (2015-2020)
  • Table 108. United Kingdom Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 109. Netherlands Abacavir Sales, by Type K Units (2015-2020)
  • Table 110. Netherlands Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 111. Rest of Europe Abacavir Sales, by Type K Units (2015-2020)
  • Table 112. Rest of Europe Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 113. MEA Abacavir Sales, by Country K Units (2015-2020)
  • Table 114. MEA Abacavir Sales, by Type K Units (2015-2020)
  • Table 115. MEA Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 116. Middle East Abacavir Sales, by Type K Units (2015-2020)
  • Table 117. Middle East Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 118. Africa Abacavir Sales, by Type K Units (2015-2020)
  • Table 119. Africa Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 120. North America Abacavir Sales, by Country K Units (2015-2020)
  • Table 121. North America Abacavir Sales, by Type K Units (2015-2020)
  • Table 122. North America Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 123. United States Abacavir Sales, by Type K Units (2015-2020)
  • Table 124. United States Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 125. Canada Abacavir Sales, by Type K Units (2015-2020)
  • Table 126. Canada Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 127. Mexico Abacavir Sales, by Type K Units (2015-2020)
  • Table 128. Mexico Abacavir Sales, by Distribution Channel K Units (2015-2020)
  • Table 129. Abacavir: by Type(USD/Units)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Abacavir: by Type(USD Million)
  • Table 140. Abacavir Tablet , by Region USD Million (2021-2026)
  • Table 141. Abacavir Oral Solution , by Region USD Million (2021-2026)
  • Table 142. Abacavir: by Distribution Channel(USD Million)
  • Table 143. Abacavir Hospital Pharmacy , by Region USD Million (2021-2026)
  • Table 144. Abacavir Retail Pharmacy , by Region USD Million (2021-2026)
  • Table 145. Abacavir Online Pharmacy , by Region USD Million (2021-2026)
  • Table 146. South America Abacavir, by Country USD Million (2021-2026)
  • Table 147. South America Abacavir, by Type USD Million (2021-2026)
  • Table 148. South America Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 149. Brazil Abacavir, by Type USD Million (2021-2026)
  • Table 150. Brazil Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 151. Argentina Abacavir, by Type USD Million (2021-2026)
  • Table 152. Argentina Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 153. Rest of South America Abacavir, by Type USD Million (2021-2026)
  • Table 154. Rest of South America Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 155. Asia Pacific Abacavir, by Country USD Million (2021-2026)
  • Table 156. Asia Pacific Abacavir, by Type USD Million (2021-2026)
  • Table 157. Asia Pacific Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 158. China Abacavir, by Type USD Million (2021-2026)
  • Table 159. China Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 160. Japan Abacavir, by Type USD Million (2021-2026)
  • Table 161. Japan Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 162. India Abacavir, by Type USD Million (2021-2026)
  • Table 163. India Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 164. South Korea Abacavir, by Type USD Million (2021-2026)
  • Table 165. South Korea Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 166. Taiwan Abacavir, by Type USD Million (2021-2026)
  • Table 167. Taiwan Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 168. Australia Abacavir, by Type USD Million (2021-2026)
  • Table 169. Australia Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 170. Rest of Asia-Pacific Abacavir, by Type USD Million (2021-2026)
  • Table 171. Rest of Asia-Pacific Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 172. Europe Abacavir, by Country USD Million (2021-2026)
  • Table 173. Europe Abacavir, by Type USD Million (2021-2026)
  • Table 174. Europe Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 175. Germany Abacavir, by Type USD Million (2021-2026)
  • Table 176. Germany Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 177. France Abacavir, by Type USD Million (2021-2026)
  • Table 178. France Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 179. Italy Abacavir, by Type USD Million (2021-2026)
  • Table 180. Italy Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 181. United Kingdom Abacavir, by Type USD Million (2021-2026)
  • Table 182. United Kingdom Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 183. Netherlands Abacavir, by Type USD Million (2021-2026)
  • Table 184. Netherlands Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 185. Rest of Europe Abacavir, by Type USD Million (2021-2026)
  • Table 186. Rest of Europe Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 187. MEA Abacavir, by Country USD Million (2021-2026)
  • Table 188. MEA Abacavir, by Type USD Million (2021-2026)
  • Table 189. MEA Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 190. Middle East Abacavir, by Type USD Million (2021-2026)
  • Table 191. Middle East Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 192. Africa Abacavir, by Type USD Million (2021-2026)
  • Table 193. Africa Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 194. North America Abacavir, by Country USD Million (2021-2026)
  • Table 195. North America Abacavir, by Type USD Million (2021-2026)
  • Table 196. North America Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 197. United States Abacavir, by Type USD Million (2021-2026)
  • Table 198. United States Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 199. Canada Abacavir, by Type USD Million (2021-2026)
  • Table 200. Canada Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 201. Mexico Abacavir, by Type USD Million (2021-2026)
  • Table 202. Mexico Abacavir, by Distribution Channel USD Million (2021-2026)
  • Table 203. Abacavir Sales: by Type(K Units)
  • Table 204. Abacavir Sales Tablet , by Region K Units (2021-2026)
  • Table 205. Abacavir Sales Oral Solution , by Region K Units (2021-2026)
  • Table 206. Abacavir Sales: by Distribution Channel(K Units)
  • Table 207. Abacavir Sales Hospital Pharmacy , by Region K Units (2021-2026)
  • Table 208. Abacavir Sales Retail Pharmacy , by Region K Units (2021-2026)
  • Table 209. Abacavir Sales Online Pharmacy , by Region K Units (2021-2026)
  • Table 210. South America Abacavir Sales, by Country K Units (2021-2026)
  • Table 211. South America Abacavir Sales, by Type K Units (2021-2026)
  • Table 212. South America Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 213. Brazil Abacavir Sales, by Type K Units (2021-2026)
  • Table 214. Brazil Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 215. Argentina Abacavir Sales, by Type K Units (2021-2026)
  • Table 216. Argentina Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 217. Rest of South America Abacavir Sales, by Type K Units (2021-2026)
  • Table 218. Rest of South America Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 219. Asia Pacific Abacavir Sales, by Country K Units (2021-2026)
  • Table 220. Asia Pacific Abacavir Sales, by Type K Units (2021-2026)
  • Table 221. Asia Pacific Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 222. China Abacavir Sales, by Type K Units (2021-2026)
  • Table 223. China Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 224. Japan Abacavir Sales, by Type K Units (2021-2026)
  • Table 225. Japan Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 226. India Abacavir Sales, by Type K Units (2021-2026)
  • Table 227. India Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 228. South Korea Abacavir Sales, by Type K Units (2021-2026)
  • Table 229. South Korea Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 230. Taiwan Abacavir Sales, by Type K Units (2021-2026)
  • Table 231. Taiwan Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 232. Australia Abacavir Sales, by Type K Units (2021-2026)
  • Table 233. Australia Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 234. Rest of Asia-Pacific Abacavir Sales, by Type K Units (2021-2026)
  • Table 235. Rest of Asia-Pacific Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 236. Europe Abacavir Sales, by Country K Units (2021-2026)
  • Table 237. Europe Abacavir Sales, by Type K Units (2021-2026)
  • Table 238. Europe Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 239. Germany Abacavir Sales, by Type K Units (2021-2026)
  • Table 240. Germany Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 241. France Abacavir Sales, by Type K Units (2021-2026)
  • Table 242. France Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 243. Italy Abacavir Sales, by Type K Units (2021-2026)
  • Table 244. Italy Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 245. United Kingdom Abacavir Sales, by Type K Units (2021-2026)
  • Table 246. United Kingdom Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 247. Netherlands Abacavir Sales, by Type K Units (2021-2026)
  • Table 248. Netherlands Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 249. Rest of Europe Abacavir Sales, by Type K Units (2021-2026)
  • Table 250. Rest of Europe Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 251. MEA Abacavir Sales, by Country K Units (2021-2026)
  • Table 252. MEA Abacavir Sales, by Type K Units (2021-2026)
  • Table 253. MEA Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 254. Middle East Abacavir Sales, by Type K Units (2021-2026)
  • Table 255. Middle East Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 256. Africa Abacavir Sales, by Type K Units (2021-2026)
  • Table 257. Africa Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 258. North America Abacavir Sales, by Country K Units (2021-2026)
  • Table 259. North America Abacavir Sales, by Type K Units (2021-2026)
  • Table 260. North America Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 261. United States Abacavir Sales, by Type K Units (2021-2026)
  • Table 262. United States Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 263. Canada Abacavir Sales, by Type K Units (2021-2026)
  • Table 264. Canada Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 265. Mexico Abacavir Sales, by Type K Units (2021-2026)
  • Table 266. Mexico Abacavir Sales, by Distribution Channel K Units (2021-2026)
  • Table 267. Abacavir: by Type(USD/Units)
  • Table 268. Research Programs/Design for This Report
  • Table 269. Key Data Information from Secondary Sources
  • Table 270. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Abacavir: by Type USD Million (2015-2020)
  • Figure 5. Global Abacavir: by Distribution Channel USD Million (2015-2020)
  • Figure 6. South America Abacavir Share (%), by Country
  • Figure 7. Asia Pacific Abacavir Share (%), by Country
  • Figure 8. Europe Abacavir Share (%), by Country
  • Figure 9. MEA Abacavir Share (%), by Country
  • Figure 10. North America Abacavir Share (%), by Country
  • Figure 11. Global Abacavir: by Type K Units (2015-2020)
  • Figure 12. Global Abacavir: by Distribution Channel K Units (2015-2020)
  • Figure 13. South America Abacavir Share (%), by Country
  • Figure 14. Asia Pacific Abacavir Share (%), by Country
  • Figure 15. Europe Abacavir Share (%), by Country
  • Figure 16. MEA Abacavir Share (%), by Country
  • Figure 17. North America Abacavir Share (%), by Country
  • Figure 18. Global Abacavir: by Type USD/Units (2015-2020)
  • Figure 19. Global Abacavir share by Players 2020 (%)
  • Figure 20. Global Abacavir share by Players (Top 3) 2020(%)
  • Figure 21. Global Abacavir share by Players (Top 5) 2020(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. GSK (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. GSK (United Kingdom) Revenue: by Geography 2020
  • Figure 25. Aurobindo (India) Revenue, Net Income and Gross profit
  • Figure 26. Aurobindo (India) Revenue: by Geography 2020
  • Figure 27. Hycultec (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Hycultec (Germany) Revenue: by Geography 2020
  • Figure 29. Lupin Limited (India) Revenue, Net Income and Gross profit
  • Figure 30. Lupin Limited (India) Revenue: by Geography 2020
  • Figure 31. Sigma-Aldrich (United States) Revenue, Net Income and Gross profit
  • Figure 32. Sigma-Aldrich (United States) Revenue: by Geography 2020
  • Figure 33. ViiV Healthcare (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. ViiV Healthcare (United Kingdom) Revenue: by Geography 2020
  • Figure 35. Cayman Chemical (United States) Revenue, Net Income and Gross profit
  • Figure 36. Cayman Chemical (United States) Revenue: by Geography 2020
  • Figure 37. Mylan (United States) Revenue, Net Income and Gross profit
  • Figure 38. Mylan (United States) Revenue: by Geography 2020
  • Figure 39. TCI Chemicals (India) Revenue, Net Income and Gross profit
  • Figure 40. TCI Chemicals (India) Revenue: by Geography 2020
  • Figure 41. Global Abacavir: by Type USD Million (2021-2026)
  • Figure 42. Global Abacavir: by Distribution Channel USD Million (2021-2026)
  • Figure 43. South America Abacavir Share (%), by Country
  • Figure 44. Asia Pacific Abacavir Share (%), by Country
  • Figure 45. Europe Abacavir Share (%), by Country
  • Figure 46. MEA Abacavir Share (%), by Country
  • Figure 47. North America Abacavir Share (%), by Country
  • Figure 48. Global Abacavir: by Type K Units (2021-2026)
  • Figure 49. Global Abacavir: by Distribution Channel K Units (2021-2026)
  • Figure 50. South America Abacavir Share (%), by Country
  • Figure 51. Asia Pacific Abacavir Share (%), by Country
  • Figure 52. Europe Abacavir Share (%), by Country
  • Figure 53. MEA Abacavir Share (%), by Country
  • Figure 54. North America Abacavir Share (%), by Country
  • Figure 55. Global Abacavir: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • GSK (United Kingdom)
  • Aurobindo (India)
  • Hycultec (Germany)
  • Lupin Limited (India)
  • Sigma-Aldrich (United States)
  • ViiV Healthcare (United Kingdom)
  • Cayman Chemical (United States)
  • Mylan (United States)
  • TCI Chemicals (India)
Select User Access Type

Key Highlights of Report


Sep 2021 154 Pages 53 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) Abacavir Quantitative research analysis
Global (United States, European Union and China) Abacavir Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Abacavir market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Abacavir market are GSK (United Kingdom), Aurobindo (India), Hycultec (Germany), Lupin Limited (India), Sigma-Aldrich (United States), ViiV Healthcare (United Kingdom), Cayman Chemical (United States), Mylan (United States) and TCI Chemicals (India), to name a few.
"Increasing Government Initiatives for HIV-ADIS Free Population " is seen as one of major influencing trends for Abacavir Market during projected period 2020-2026.

Know More About Global (United States, European Union and China) Abacavir Report?

Have a Query? Click Here

Other Related Reports

Virus Like Particles Comprehensive Study by Type (Adeno-Associated Virus, HIV, Hepatitis B Virus, Hepatitis C Virus, Others), Application (Vaccines, Mycoviruses, Virus Research, Therapeutic and Imagi...
$ 3500
Pet Vaccine Comprehensive Study by Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), Mode of Administra...
$ 3650
Typhoid Vaccine Comprehensive Study by Type (Oral, Injection), Application (Hospital, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, Others) Players and Region - Global M...
$ 3500
Clostridium Difficile Treatment Comprehensive Study by Type (Narrow Spectrum Antibiotics, Broad Spectrum Antibiotics), Route of Administration (Oral, Intravenous / Parenteral), Distribution Channel (...
$ 3750
Clinical Trial Packaging Comprehensive Study by Packaging (Syringes, Vials & Ampoules, Bottles, Bags & Pouches, Tubes, Sachets, Kits or Packs, Others), End-User (Research Laboratories, Clinical Resea...
$ 3500
Omeprazole Comprehensive Study by Type (Capsule, Powder, Tablet, Suspension), Application (Gastroesophageal Reflux Disease (GERD), Barrett's Oesophagus, Duodenal Ulcer, Erosive Esophagitis, Hiatal He...
$ 3750